Target intelligence / Profile preview

RNA, U6 small nuclear 159, pseudogene (RNU6-159P)

Target: RNU6-159P
Molecular classification: Pseudogene, Non-coding RNA-derived pseudogene, Other

Overview

RNU6-159P is a **processed pseudogene** that originated from retrotransposition of the U6 spliceosomal small nuclear RNA (snRNA) gene, a key non-coding RNA component of the spliceosome complex. Unlike functional U6 snRNA, which catalyzes intron excision as part of pre-mRNA splicing[1][3], RNU6-159P does not participate in splicing or encode a functional product. The presence of multiple U6-derived pseudogenes in the genome reflects retrotransposition and template switching events by LINE retroelements[5]. Like most pseudogenes, RNU6-159P is considered molecular "fossil" and lacks demonstrated biological activity, disease involvement, or drug targeting capacity in current literature[5].

Other names: RNU6-159PRNA, U6 small nuclear 159, pseudogene

Mechanism of action

None (no mechanism of action; not a drug target).

Biological functions

None known (as a pseudogene, does not carry out the biological functions performed by U6 snRNA)

Disease associations

Other (no direct disease implication or functional role established for RNU6-159P; most pseudogenes do not have established disease roles unless expressed or functioning in regulatory networks)

Safety considerations

None (as a pseudogene, it does not raise safety or therapeutic challenges).

Interacting drugs

None (no drugs interact with RNU6-159P; it is not a target for pharmacological intervention).

Biomarkers

None reported

Beyond the preview

Go deeper on RNA, U6 small nuclear 159, pseudogene (RNU6-159P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 159, pseudogene (RNU6-159P).

Explore the full profile